These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Lysophosphatidic acid up-regulates IL-10 production to inhibit TNF-α synthesis in Mϕs stimulated with LPS. Ciesielska A; Hromada-Judycka A; Ziemlińska E; Kwiatkowska K J Leukoc Biol; 2019 Dec; 106(6):1285-1301. PubMed ID: 31335985 [TBL] [Abstract][Full Text] [Related]
4. Heterotrimeric Gα(i) proteins are regulated by lipopolysaccharide and are anti-inflammatory in endotoxemia and polymicrobial sepsis. Fan H; Li P; Zingarelli B; Borg K; Halushka PV; Birnbaumer L; Cook JA Biochim Biophys Acta; 2011 Mar; 1813(3):466-72. PubMed ID: 21255617 [TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidic acid receptor 1 modulates lipopolysaccharide-induced inflammation in alveolar epithelial cells and murine lungs. Zhao J; He D; Su Y; Berdyshev E; Chun J; Natarajan V; Zhao Y Am J Physiol Lung Cell Mol Physiol; 2011 Oct; 301(4):L547-56. PubMed ID: 21821728 [TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidic acid as a mediator for proinflammatory agonists in a human corneal epithelial cell line. Zhang Z; Liu Z; Meier KE Am J Physiol Cell Physiol; 2006 Nov; 291(5):C1089-98. PubMed ID: 16760261 [TBL] [Abstract][Full Text] [Related]
7. Dipyridamole activation of mitogen-activated protein kinase phosphatase-1 mediates inhibition of lipopolysaccharide-induced cyclooxygenase-2 expression in RAW 264.7 cells. Chen TH; Kao YC; Chen BC; Chen CH; Chan P; Lee HM Eur J Pharmacol; 2006 Jul; 541(3):138-46. PubMed ID: 16765938 [TBL] [Abstract][Full Text] [Related]
8. Enhancement of survival by LPA via Erk1/Erk2 and PI 3-kinase/Akt pathways in a murine hepatocyte cell line. Sautin YY; Crawford JM; Svetlov SI Am J Physiol Cell Physiol; 2001 Dec; 281(6):C2010-9. PubMed ID: 11698260 [TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor 4 coupled GI protein signaling pathways regulate extracellular signal-regulated kinase phosphorylation and AP-1 activation independent of NFkappaB activation. Fan H; Peck OM; Tempel GE; Halushka PV; Cook JA Shock; 2004 Jul; 22(1):57-62. PubMed ID: 15201703 [TBL] [Abstract][Full Text] [Related]
10. Effects of Ginkgo biloba extract (EGb 761) and quercetin on lipopolysaccharide-induced signaling pathways involved in the release of tumor necrosis factor-alpha. Wadsworth TL; McDonald TL; Koop DR Biochem Pharmacol; 2001 Oct; 62(7):963-74. PubMed ID: 11543732 [TBL] [Abstract][Full Text] [Related]
11. Suppression of inflammation response by a novel A₃ adenosine receptor agonist thio-Cl-IB-MECA through inhibition of Akt and NF-κB signaling. Lee HS; Chung HJ; Lee HW; Jeong LS; Lee SK Immunobiology; 2011 Sep; 216(9):997-1003. PubMed ID: 21514967 [TBL] [Abstract][Full Text] [Related]
12. VIP deficient mice exhibit resistance to lipopolysaccharide induced endotoxemia with an intrinsic defect in proinflammatory cellular responses. Abad C; Tan YV; Cheung-Lau G; Nobuta H; Waschek JA PLoS One; 2012; 7(5):e36922. PubMed ID: 22615845 [TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic acid-induced proliferation in opossum kidney proximal tubular cells: role of PI 3-kinase and ERK. Dixon RJ; Brunskill NJ Kidney Int; 1999 Dec; 56(6):2064-75. PubMed ID: 10594782 [TBL] [Abstract][Full Text] [Related]
14. Dexmedetomidine inhibits LPS-induced inflammatory responses through peroxisome proliferator-activated receptor gamma (PPARγ) activation following binding to α Fujimoto M; Higuchi H; Honda-Wakasugi Y; Miyake S; Nishioka Y; Yabuki-Kawase A; Maeda S; Miyawaki T Eur J Pharmacol; 2021 Feb; 892():173733. PubMed ID: 33220278 [TBL] [Abstract][Full Text] [Related]
15. Attenuation of LPS-induced cyclooxygenase-2 and inducible NO synthase expression by lysophosphatidic acid in macrophages. Chien HY; Lu CS; Chuang KH; Kao PH; Wu YL Innate Immun; 2015 Aug; 21(6):635-46. PubMed ID: 25783839 [TBL] [Abstract][Full Text] [Related]
17. Differential effects of 15-deoxy-delta(12,14)-prostaglandin J2 and a peroxisome proliferator-activated receptor gamma agonist on macrophage activation. Guyton K; Bond R; Reilly C; Gilkeson G; Halushka P; Cook J J Leukoc Biol; 2001 Apr; 69(4):631-8. PubMed ID: 11310850 [TBL] [Abstract][Full Text] [Related]
18. Nodakenin suppresses lipopolysaccharide-induced inflammatory responses in macrophage cells by inhibiting tumor necrosis factor receptor-associated factor 6 and nuclear factor-κB pathways and protects mice from lethal endotoxin shock. Rim HK; Cho W; Sung SH; Lee KT J Pharmacol Exp Ther; 2012 Sep; 342(3):654-64. PubMed ID: 22637723 [TBL] [Abstract][Full Text] [Related]
19. Lysophosphatidic acid is an osteoblast mitogen whose proliferative actions involve G(i) proteins and protein kinase C, but not P42/44 mitogen-activated protein kinases. Grey A; Banovic T; Naot D; Hill B; Callon K; Reid I; Cornish J Endocrinology; 2001 Mar; 142(3):1098-106. PubMed ID: 11181524 [TBL] [Abstract][Full Text] [Related]
20. Akt activation induced by lysophosphatidic acid and sphingosine-1-phosphate requires both mitogen-activated protein kinase kinase and p38 mitogen-activated protein kinase and is cell-line specific. Baudhuin LM; Cristina KL; Lu J; Xu Y Mol Pharmacol; 2002 Sep; 62(3):660-71. PubMed ID: 12181443 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]